Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Oliver W. Press

Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Hodgkin lymphoma Non-Hodgkin lymphoma

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Hodgkin lymphoma Non-Hodgkin lymphoma

Franziska Michor

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Hodgkin lymphoma Non-Hodgkin lymphoma

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Non-Hodgkin lymphoma

Stanley R. Riddell

Targeted therapy of B cell malignances with CAR-T cells of defined composition

Non-Hodgkin lymphoma

Christopher S Carlson

Monitoring disease progression in follicular lymphoma with next-gen sequencing

Non-Hodgkin lymphoma

Pathology

Paul Anthony Wender

Synthetic Studies Related to Cancer Research/Treatment

Hodgkin lymphoma Non-Hodgkin lymphoma

Arash Ash Alizadeh

Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer Pathology Hematology and hematologic malignancies